Phase 3 trial of coronavir (favipiravir) in patients with mild to moderate COVID-19.
Ruzhentsova TA, Oseshnyuk RA, Soluyanova TN, Dmitrikova EP, Mustafaev DM, Pokrovskiy KA, Markova ТN, Rusanova MG, Kostina NE, Agafina AS, Brook YF, Bronov OY, Shults EI, Filon OV.
Ruzhentsova TA, et al. Among authors: markova n.
Am J Transl Res. 2021 Nov 15;13(11):12575-12587. eCollection 2021.
Am J Transl Res. 2021.
PMID: 34956474
Free PMC article.